克罗托诺化物诱导铁和线粒体功能障碍在AML
Chenchen Ma1, Jinxin Wang2, Siyuan Cui2
1Central Laboratory of Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250014, China.
European journal of pharmacology
|June 24, 2025
概括
克罗托诺化物通过破坏线粒体来抑制急性髓性白血病 (AML) 细胞生长,导致反应性氧物种 (ROS) 积累并触发铁亡. 这种化合物还通过p62/KEAP1通路影响自.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 克罗托诺赛德是一种瓜异构体,对急性髓性白血病 (AML) 细胞系表现出抑制作用.
- 克罗托诺赛德抗白血病活性的精确机制尚未完全理解.
- 之前的研究表明,克罗托诺赛德的机制不是单一的,这促使进一步调查.
研究的目的:
- 为了研究克罗托诺赛德对AML细胞中线粒体功能的影响.
- 为了确定克罗托诺赛德是否会在AML细胞中诱导铁.
- 为了阐明分子途径涉及到crotonoside诱导的细胞死亡.
主要方法:
- 在KG-1a和Molm-13细胞系中评估线粒体呼吸,膜潜力和质量.
- 测量与ferroptosis相关的参数.
- 分子对接模拟以确定潜在的分子目标.
- 对p62/KEAP1信号通路和自细胞调节的分析.
主要成果:
- 克罗托诺化物诱导线粒体损伤,导致功能障碍和增加反应性氧物种 (ROS) 生产.
- 观察到的线粒体损伤会在AML细胞中触发铁亡.
- 分子对接表明克罗托诺化物抑制了线粒体DNA聚合酶 γ.
- 克罗托诺赛德通过p62/KEAP1通路调节AML细胞自.
结论:
- 克罗托诺oside通过诱导线粒体功能障碍和铁亡来发挥其抗AML作用.
- 抑制线粒体DNA聚合酶γ似乎是一个关键机制.
- 克罗托诺赛德通过p62/KEAP1途径对自的影响与ferroptosis诱导有关.
- 需要进一步的研究,以充分阐明线粒体DNA聚合酶 γ抑制和随后的铁灭的机制.
关键词:
在AML,AML就是AML.这就是Crotonoside.DNA聚合物 γ DNA聚合物 γ铁性化 (ferroptosis) 是一种线粒体功能障碍 线粒体功能障碍这是什么意思? Mt DNA DNA Mt DNA更多相关视频
相关概念视频
Necrosis
4.9K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.9K
Electron Transport Chain: Complex I and II
15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.1K


